Prometheus Biosciences Provides Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference

NEXT STORY
Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results
PREV STORY
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology

IRVING, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the ...

author_avatar
NASDAQ Market News

MediWound Expands Latin American Distribution of NexoBrid Through Agreement With Avalon Pharmaceutical S.A

YAVNE, Israel, Jan. 21, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical ...

author_avatar
NASDAQ Market News

Physeon Announces Enrollment of First Patient in US “VIVA” Trial for Veinplicity

Important Milestone for Veinplicity Study  SCHAFFHAUSEN, Switzerland, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Physeon ...

author_avatar
NASDAQ Market News